Actinium Share Price

Actinium Share Price

AMEX: ATNM | Micro Cap | Healthcare
$1.07
-$0.02 (-1.83%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Actinium Stock Performance

Open
$1.05
Prev. Close
$1.09
Circuit Range
N/A
Day Range
$1.04 - $1.08
Year Range
$0.75 - $1.72
Volume
4,446
Average Traded
$1.06

Actinium Share Price Today

As of 21 November 2026, Actinium Pharmaceuticals, Inc's share price is $1.07. The stock opened at $1.05, compared to its previous close of $1.09. During today's trading session, Actinium Pharmaceuticals, Inc's share price traded between $1.04 and $1.08, with an average price of $1.06. Over the past 52 weeks, the stock has recorded a high of $1.72 and a low of $0.75. In terms of performance, Actinium Pharmaceuticals, Inc's share price has declined by 14.74% over the last six months and is down 23.84% on a year-on-year basis.

Actinium Share Price Chart

Line chart of the Actinium price trend over the selected period. The price fell overall, ranging from 1.04 to 1.09, ending at 1.07.
$1.04$1.08
L
Show Current Price
H

Actinium Stock Fundamentals & Key Indicators

Market Cap
$33.38M
PE Ratio (TTM)
3.18
Dividend Yield
0.00%
EPS (TTM)
$0.34
Revenue (TTM)
$90.00M
Return On Equity (TTM)
43.10%
Profit Margin
-37655.56%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
1.68%

Actinium Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$35.00$0.00
Net Profit-$5.94-$5.52$27.90-$5.84
Net Profit MarginN/AN/A79.71%N/A
Income ChangeN/A7.07%605.43%-120.93%

Actinium Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.03$0.08$0.00$0.09
Net Profit-$33.02-$48.82-$38.24-$33.89
Net Profit Margin-3205.83%-61025.00%N/A-37655.56%
Income ChangeN/A-47.85%21.67%11.38%

Actinium Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets2.392.393.183.25
Current Assets49.3874.5178.26110.94
Total Assets51.7876.981.45114.19
Non Current Liabilities35.9735.9936.5737.08
Current Liabilities7.978.158.4910.63
Total Liabilities43.9444.1445.0747.71
Shareholders' Equity7.8332.7636.3866.48

Actinium Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-24.58-33.07-47.348.64
Investing-0.1-0.01-0.15-0.37
Financing-0.2229.3214.8723.11

Corporate Actions

Split
Ex-date: 11 Aug 2020

About Actinium

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Actinium Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.48
$1.05
-30.00%
Oct 2026
$1.15
$1.50
+30.43%
Sep 2026
$1.02
$1.15
+13.41%
Aug 2026
$0.85
$1.01
+20.71%
Jul 2026
$0.97
$0.84
-14.37%
Jun 2026
$1.21
$0.98
-21.83%
May 2026
$1.13
$1.25
+12.05%
Apr 2026
$0.99
$1.12
+14.05%
Mar 2026
$1.16
$0.98
-18.17%
Feb 2026
$1.22
$1.20
+3.45%
Jan 2026
$1.35
$1.16
-15.33%
Dec 2025
$1.39
$1.37
-2.49%

Actinium Share Price FAQs